Kenneth M. Pfarr

Sigmund Freud Str. 25
Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 86 publications

Activity of Corallopyronin A Against ESKAPEE Pathogens: Potential and Translational Implications.

Activity of Corallopyronin A Against ESKAPEE Pathogens: Potential and Translational Implications.

Journal: Antibiotics (Basel, Switzerland)

Published: June 12, 2026

Constrained RNA polymerase mutational pathways distinguish corallopyronin A resistance from rifampicin resistance in staphylococci.

Constrained RNA polymerase mutational pathways distinguish corallopyronin A resistance from rifampicin resistance in staphylococci.

Journal: Scientific reports

Published: April 07, 2026

Sustained Drug Exposure Drives Efficacy in Mice: PK/PD Analysis of Corallopyronin A against Wolbachia using Physiologically Based Absorption Modeling.

Sustained Drug Exposure Drives Efficacy in Mice: PK/PD Analysis of Corallopyronin A against Wolbachia using Physiologically Based Absorption Modeling.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: March 12, 2026

Assessing the efficacy of high-dose rifampicin plus albendazole against onchocerciasis.

Assessing the efficacy of high-dose rifampicin plus albendazole against onchocerciasis.

Journal: PLoS neglected tropical diseases

Published: March 01, 2026

Breaking Down Barriers: CorA Effectively Targets Staphylococcal Biofilms in Vitro and in Vivo.

Breaking Down Barriers: CorA Effectively Targets Staphylococcal Biofilms in Vitro and in Vivo.

Journal: ChemMedChem

Published: November 20, 2025

Improved RNA preparation for RNA-seq of the intracellular bacterium Wolbachia wAlbB.

Improved RNA preparation for RNA-seq of the intracellular bacterium Wolbachia wAlbB.

Journal: Frontiers in microbiology

Published: July 16, 2025

Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections.

Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections.

Journal: Infection

Published: June 20, 2025

Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes.

Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes.

Journal: bioRxiv : the preprint server for biology

Published: February 03, 2025

Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes.

Fexinidazole and Corallopyronin A target Wolbachia-infected sheath cells present in filarial nematodes.

Journal: PLoS pathogens

Published: January 20, 2025

No resistance development against corallopyronin A in Wolbachia in C6/36 cell culture.

No resistance development against corallopyronin A in Wolbachia in C6/36 cell culture.

Journal: International journal of antimicrobial agents

Published: August 06, 2024

Erratum for Balthazar et al., "A laboratory-based predictive pathway for the development of Neisseria gonorrhoeae high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase".

Erratum for Balthazar et al., "A laboratory-based predictive pathway for the development of Neisseria gonorrhoeae high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase".

Journal: Microbiology spectrum

Published: July 01, 2024

The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis.

The long and winding road towards new treatments against lymphatic filariasis and onchocerciasis.

Journal: Trends in parasitology

Published: May 30, 2024

Showing 1-12 of 86

Last Updated: 09/26/2026